Description of Collaborative Activity: |
To help address the COVID-19 pandemic, National Institute of Biomedical Imaging and Bioengineering (NIBIB) received $500 million to support the development of new SARS-CoV-2 virus testing technologies. The funding is part of the fourth congressional supplement (PPP Act). Additional funds ($307 mil) from Biomedical Advanced Research and Development Authority (BARDA) were transferred and an additional appropriations ($100 mil) from the fifth congressional supplement. The Rapid Acceleration of Diagnostics (RADx) Tech program is leveraging NIBIB's existing Point-of-Care Technologies Research Network (POCTRN) to accelerate the development, validation, and commercialization of innovative POC and home-based tests, as well as improvements to existing clinical laboratory methods. RADx Tech is supporting the full range of product development including technology validation, clinical translation, commercialization, and product distribution. General information about the RADx Tech https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-tech RADx Tech dashboard - https://www.nibib.nih.gov/covid-19/radx-initiative-dashboard |
